Drug maker Novo Nordisk expects lower US prices next year


Novo Nordisk, the world's top maker of diabetes drugs, on Wednesday reported second-quarter operating profit broadly in line with forecasts, but said prices in the key U.S. market would be lower next year. FILE PHOTO: The logo of Danish multinational pharmaceutical company Novo Nordisk is pictured on the facade of a production plant in Chartres, north-central France, April 21, 2016.



from Biotech News